These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26427291)

  • 1. [Future of implantable electrical cardiac devices].
    Daubert JC; Behaghel A; Leclercq C; Mabo P
    Bull Acad Natl Med; 2014 Mar; 198(3):473-87; discussion 487-8. PubMed ID: 26427291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients.
    Auricchio A; Delnoy PP; Regoli F; Seifert M; Markou T; Butter C;
    Europace; 2013 Aug; 15(8):1191-7. PubMed ID: 23703364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on right ventricular outflow tract septal pacing.
    Da Costa A; Gabriel L; Romeyer-Bouchard C; Géraldine B; Gate-Martinet A; Laurence B; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(6-7):394-403. PubMed ID: 23850059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable device therapy.
    Goldenberg I; Moss AJ
    Prog Cardiovasc Dis; 2008; 50(6):449-74. PubMed ID: 18474287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac device therapy 1: theory, technology and terminology.
    Modi S; Rao A; Hughes S; Ramsdale D
    Br J Hosp Med (Lond); 2008 Nov; 69(11):620-4. PubMed ID: 19069261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.
    Auricchio A; Delnoy PP; Butter C; Brachmann J; Van Erven L; Spitzer S; Moccetti T; Seifert M; Markou T; Laszo K; Regoli F;
    Europace; 2014 May; 16(5):681-8. PubMed ID: 24497573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Cappato R; Ali H
    Int J Cardiol; 2017 Jun; 237():38-41. PubMed ID: 28377192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leadless Cardiac Pacemakers: Current status of a modern approach in pacing.
    Sideris S; Archontakis S; Dilaveris P; Gatzoulis KA; Trachanas K; Sotiropoulos I; Arsenos P; Tousoulis D; Kallikazaros I
    Hellenic J Cardiol; 2017; 58(6):403-410. PubMed ID: 28529181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint.
    Boriani G; Diemberger I; Biffi M; Martignani C; Ziacchi M; Bertini M; Valzania C; Bronzetti G; Rapezzi C; Branzi A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):422-33. PubMed ID: 17367364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of basic electrical features of ICD defibrillating leads implanted to right ventricular apex or right ventricular outflow track and septum].
    Szafraniec Z; Kaczmarek K; Pałka K; Ptaszyński P; Ruta J; Chudzik M; Wranicz JK
    Pol Merkur Lekarski; 2014 Mar; 36(213):155-9. PubMed ID: 24779211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac remodelling and function after cardiovascular implantable electronic devices implantation].
    Stanek A; Lelakowski J; Matusik PT
    Pol Merkur Lekarski; 2019 Apr; 46(274):187-189. PubMed ID: 31099767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy: which device to implant?
    Leclercq C; Mabo C; Daubert JC
    Arch Cardiovasc Dis; 2008 Jan; 101(1):55-60. PubMed ID: 18391874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.